Skip to content

GoodRx Holdings, Inc. GDRX Loss Contingency Accrual

Loss Contingency Accrual at other companies

Doximity logo
DoximityDOCS

Other financials

Income statement

See full
Revenue$194.0M-4.4%
Gross profit$173.9M-8.3%
Operating income$14.0M-40.1%
Net income$1.2M-89.4%
EPS (diluted)$0.00-100%

Balance sheet

See full
Cash & equivalents$235.7M-21.7%
Total debt$541.4M0.0%
Total equity$622.0M-4.9%
Total assets$2.0B+56.0%

Cash flow

See full
Operating cash flow$11.8M+25.8%
CapEx$1.1M+700%
Free cash flow$10.7M+15.4%

Valuation

See full
Market cap$911.04M-44.5%
Enterprise value$1.22B-35.4%
P/E44.3×-13.4×
P/S1.2×-0.9×

Profitability

See full
Gross margin91.8%-2.0pp
Operating margin9.9%-0.3pp
Net margin2.6%-1.0pp
FCF margin21%+2.3pp

Returns & leverage

See full
Return on equity3.2%-1.2pp
Debt / equity0.9×0.0×
Current ratio1.5×-3.8×

Where this comes from

Reported directly by GoodRx Holdings, Inc. in its filing.

Tagged under the XBRL concept us-gaap:LossContingencyAccrualAtCarryingValue.

The official record: GoodRx Holdings, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about GoodRx Holdings, Inc.'s loss contingency accrual.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is GoodRx Holdings, Inc.'s loss contingency accrual?
GoodRx Holdings, Inc. (GDRX) reported loss contingency accrual of $30.5M in Q1 2026.
How has GoodRx Holdings, Inc.'s loss contingency accrual changed year-over-year?
GoodRx Holdings, Inc.'s loss contingency accrual increased by 21.9% year-over-year, from $25.02M to $30.5M.
What is the long-term trend for GoodRx Holdings, Inc.'s loss contingency accrual?
Over 3 years (2022 to 2025), GoodRx Holdings, Inc.'s loss contingency accrual has grown at a 172.9% compound annual growth rate (CAGR), from $1.5M to $30.5M.